Sequence alignment of mouse DXO (MmDXO), human DXO (HsDXO), S. pombe Rai1 (SpRai1), yeast Rai1 (ScRai1), K. lactis Dxo1 (KlDxo1) and yeast Dxo1 (ScDxo1). The four conserved motifs are shown in red and labeled. Additional conserved residues are shown in magenta. Residues that contact the pU5 oligonucleotide are marked with the red circles, while those that contact m 7 GpppG with the blue circles. The secondary structure elements for mouse DXO are indicated at the top of the alignment. Upper case italic characters in SpRai1 and KlDxo1 indicate additional residues in the secondary structure elements of those structures, while lower case letters indicate residues that do not belong to the secondary structure elements. Lower case italic characters indicate residues that are disordered in the structures. 
Supplemental Experimental Procedures Protein Expression and Purification
Full-length DXO coding region inserted into the pET28a vector (Novagen, with Nterminal His-tag) was used to express His-tagged DXO. The protein was over-expressed in E. coli BL21 Rosetta (DE3) cells at 20 °C. The cells were lysed by sonication, and the recombinant protein was purified by Ni-NTA (Qiagen) and gel filtration (Sephacryl S-300, GE Healthcare) chromatography. Purified DXO was concentrated to 10 mg/ml in a buffer containing 20 mM Tris (pH 7.5), 200 mM NaCl, 2 mM DTT and 5% (v/v) glycerol, flash frozen in liquid nitrogen and stored at -80C.
Cell Culture and Generation of Stably Transformed Knockdown Cell Lines
Cells transfected with plasmids encoding shRNA specifically targeting DXO mRNA 908-929bp and control nonspecific shRNA plasmids were obtained from Sigma-Aldrich and transfected into 293T or U2OS cells with Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. Stably transformed 293T cells expressing FLAG tagged DXO were generated by transfecting 293T cells with pIRES-puro-FLAG-DXO plasmid and monoclonal cells stably express FLAG-DXO were selected. 293T control and stable cell lines were cultured in DMEM/10% FBS medium and harvested at about 75% cell density and extract prepared as previously described (Jiao et al., 2006) . After a 1× PBS wash, cells were suspended in cold lysis buffer (10mM KCl, 10mM Tris-HCl (pH 7.0), 2mM DTT, 1.5mM MgCl, 0.25% Triton X-100, protease inhibitors (Complete Protease Inhibitor Cocktail Tablets; Roche)) and incubated on ice for 30 minutes. Cells were vortexed for 30 seconds and unbroken cells removed by a 300g centrifugation.
Nuclei were cleared by a 2000g centrifugation at 4 o C and washed once with cold 1× PBS.
Nuclear extracts were prepared by sonication in PBS buffer containing protease inhibitors.
RNA Decapping and In Vitro Decay Assay
Decapping assays were carried out with His-tagged mouse DXO or mutant DXO recombinant protein (25nM) and nuclear extracts (50µg) incubated with 32 P-cap-labeled or 32 P-5´end-labeled pcP RNAs in decapping buffer as previously described (Jiao et al., 2010) The decay reactions were terminated with phenol:chloroform extractions and resolved by 5% denaturing polyacrylamide gel electrophoresis (Jiao et al., 2010) . The TLC plates or dried gels were detected with a Molecular Dynamics PhosphorImager (Storm860) and quantified using ImageQuant-5 software. Fluorescent-based exonuclease assays were carried out as described (Chang et al., 2012) .
Western Blot Assays
Western blot analysis was carried out as previously described (Jiao et al., 2009 ) with polyclonal anti-Dom3Z antibody (1:500 dilution; Proteintech) and monoclonal anti-eIF4E antibody (1:1500 dilution; Transduction Laboratories) from control or DXO KD 293T
cells.
